Literature DB >> 2449121

Bacteriostatic action of streptomycin on ribosomally resistant mutants (rpsL) of Salmonella typhimurium.

R O Fernández1, D N Antón.   

Abstract

Incubation of streptomycin-resistant (rpsL) mutants of Salmonella typhimurium in alkaline nutrient medium containing streptomycin brought about an inhibition of cell growth that was readily reversed by removing the antibiotic or neutralizing the medium. Growth inhibition was maximal at pH 8.2 and a streptomycin concentration of 800 micrograms/ml. A similar amount of dihydrostreptomycin had a negligible effect, and 10-times-higher concentrations of this antibiotic were required to reproduce the streptomycin action. Addition of streptomycin (400 micrograms/ml) to rpsL cells in alkaline (pH 8.2) nutrient medium caused inhibition of protein and DNA synthesis and also, but to a lower degree, of RNA synthesis. This effect on macromolecular synthesis was not due to ATP deprivation, since ATP content rose after addition of the antibiotic. At pH 8.2, the rate of entrance of streptomycin increased fourfold with respect to the rate at pH 7.0, leading to a large accumulation of streptomycin into rpsL cells. Uptake of the antibiotic was halted by addition of KCN or chloramphenicol. Equal uptake was obtained with 800 micrograms of dihydrostreptomycin or 400 micrograms of streptomycin per ml, yet the former did not affect cell growth at that concentration. It is concluded that high pH stimulates streptomycin and dihydrostreptomycin uptake by rpsL strains but only streptomycin accumulation causes growth inhibition in cells lacking the high-affinity ribosomal site.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2449121      PMCID: PMC175003          DOI: 10.1128/AAC.31.10.1627

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Uptake of 14C-streptomycin by some microorganisms and its relation to their streptomycin sensitivity.

Authors:  R HANCOCK
Journal:  J Gen Microbiol       Date:  1962-07

2.  Uptake of streptomycin by Escherichia coli.

Authors:  N ANAND; B D DAVIS; A K ARMITAGE
Journal:  Nature       Date:  1960-01-02       Impact factor: 49.962

3.  Envelope mutation promoting autolysis in Salmonella typhimurium.

Authors:  D N Antón; L V Orce
Journal:  Mol Gen Genet       Date:  1976-02-27

Review 4.  Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants.

Authors:  R E Hancock
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

5.  Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa.

Authors:  L E Bryan; H M Van den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

6.  Effect of growth rate on streptomycin accumulation by Escherichia coli and Bacillus megaterium.

Authors:  M E Muir; R S van Heeswyck; B J Wallace
Journal:  J Gen Microbiol       Date:  1984-08

7.  Binding of dihydrostreptomycin to Escherichia coli ribosomes: characteristics and equilibrium of the reaction.

Authors:  F N Chang; J G Flaks
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

8.  Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics.

Authors:  P D Damper; W Epstein
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

9.  Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.

Authors:  L E Bryan; H M Van Den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

Review 10.  Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells.

Authors:  R E Hancock
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.